Financials
Financial year 2025
Associatie Nefrologie AZ Sint–Lucas Assebroek from Brugge, company number BE0693956707, closed financial year 2025 with a result of € 0 after tax. For that financial year Associatie Nefrologie AZ Sint–Lucas Assebroek recorded a gross margin of € 5,227 and equity of € 10,106. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 10,106
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 14,891
▼ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 0.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,796
▲ 112% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,566
▲ 222% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 6,292 | € 3,815 | € 3,753 | € 5,227 | ▲ 39% |
| Equity | € 10,106 | € 10,106 | € 10,106 | € 10,106 | |
| Total debts | € 1,147,266 | € 1,223,625 | € 1,248,306 | € 1,098,447 | ▼ 12% |
| Cash | € 18,021 | € 21,752 | € 20,395 | € 14,891 | ▼ 27% |
| Bank debt | € 2,330 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 1,157,372 | € 1,233,731 | € 1,258,412 | € 1,108,553 | ▼ 12% |
By gross margin, Associatie Nefrologie AZ Sint–Lucas Assebroek ranks 52nd of 54 companies with main activity “Activiteiten van medisch specialisten” in Brugge that publish figures (fiscal year 2025).
Key figures of Associatie Nefrologie AZ Sint–Lucas Assebroek, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Associatie Nefrologie AZ Sint–Lucas Assebroek the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Associatie Nefrologie AZ Sint–Lucas Assebroek?
What happened at Associatie Nefrologie AZ Sint–Lucas Assebroek in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
- Paronef BV became a director. NBB
- New establishment in Brugge. KBO
- Horizon BV became a director. NBB
- Dr. Laute Margo, Nefrologie BV became a director. NBB
- Dr. Sylvie Vermeire Nefrologie BV became a director. NBB
- Dr. Grijalba - Dr. Reyns BV became a director. NBB
- Drs. Huygens-Vandermarliere BV became a director. NBB
In short
From € 0 profit in 2022 to € 0 profit in 2025.
Paid € 8,224 in corporate taxes since 2022.
Management
The stake of Dr. Grijalba - Dr. Reyns, DR.SYLVIE VERMEIRE NEFROLOGIE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Associatie Nefrologie AZ Sint–Lucas AssebroekBehind Associatie Nefrologie AZ Sint–Lucas Assebroek are Horizon BV, Dr. Laute Margo, Nefrologie BV, Dr. Sylvie Vermeire Nefrologie BV, Dr. Grijalba - Dr. Reyns BV, Drs. Huygens-Vandermarliere BV and Paronef BV. The shares are held by Dr. Grijalba - Dr. Reyns (14.3%) and DR.SYLVIE VERMEIRE NEFROLOGIE (12.5%).
Directors
According to the 2025 annual accounts
Director · represented by Dr. Luyckx Christine
since 2018
Dr. Laute Margo, Nefrologie BV
Director · represented by Dr. Margo Laute
since 2018
Dr. Sylvie Vermeire Nefrologie BV
Director · represented by Dr. Sylvie Vermeire
since 2018
Chairman of the board · represented by Dr. Liza-Maria Reyns
since 2018
Drs. Huygens-Vandermarliere BV
Director · represented by Dr. Annemie Vandermarliere
since 2018
Director · represented by Dr. Pannecoeck Roos
since 2025
Director · represented by Dr. Bert Vandewiele
since 2018
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Sint-Lucaslaan 29
8310 Brugge
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Brugge
Same main activity (Activiteiten van medisch specialisten), 56 active companies in Brugge, largest first.
€ 1.4 million gross margin · 2025
Dr. Vanfleteren Marc, radiologie - röntgendiagnose
€ 1 million gross margin · 2025
€ 873,071 gross margin · 2025
€ 803,643 gross margin · 2025
Dr. Matthias Desmet - Dr. Sofie Decock
€ 759,974 gross margin · 2025
Dr. Vermander - Dr. Vandewalle
€ 657,321 gross margin · 2025
Details
- Company number
- 0693.956.707
- VAT number
- BE 0693.956.707
- Registered office
- Sint-Lucaslaan 29, 8310 Brugge
- Names & denominations
- Associatie Nefrologie AZ Sint–Lucas Assebroek
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 April 2018
- Peppol
- Active · Active since 28 Jul 2026
- Activities · NACE
Activiteiten van medisch specialisten